Page last updated: 2024-10-22

anastrozole and Thromboembolism

anastrozole has been researched along with Thromboembolism in 3 studies

Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.

Research Excerpts

ExcerptRelevanceReference
"The third-generation aromatase inhibitors (AIs) anastrozole, exemestane and letrozole have largely replaced tamoxifen as the preferred treatment for hormone receptor - positive breast cancer in postmenopausal women."4.84The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer. ( Fabian, CJ, 2007)
"Both anastrozole and tamoxifen were well tolerated."2.70Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. ( Bonneterre, J; Buzdar, A; Nabholtz, JM; Robertson, JF; Sahmoud, T; Steinberg, M; Thürlimann, B; von Euler, M; Webster, A, 2001)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lewis, S1
Fabian, CJ1
Bonneterre, J1
Buzdar, A1
Nabholtz, JM1
Robertson, JF1
Thürlimann, B1
von Euler, M1
Sahmoud, T1
Webster, A1
Steinberg, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Trial With Factorial Design Comparing Fulvestrant ± Lapatinib ± Aromatase Inhibitor in Metastatic Breast Cancer Progressing After Aromatase Inhibitor Therapy[NCT02394496]Phase 3396 participants (Anticipated)Interventional2007-11-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for anastrozole and Thromboembolism

ArticleYear
Do endocrine treatments for breast cancer have a negative impact on lipid profiles and cardiovascular risk in postmenopausal women?
    American heart journal, 2007, Volume: 153, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular

2007
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer.
    International journal of clinical practice, 2007, Volume: 61, Issue:12

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Chemot

2007

Trials

1 trial available for anastrozole and Thromboembolism

ArticleYear
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.
    Cancer, 2001, Nov-01, Volume: 92, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Doub

2001